NSE: VIJAYA · 30 October 2026
- Vijaya Diagnostic Centre Ltd. (VIJAYA) fell 1.26% during the trading session, closing at ₹1,445.70 after moving between a day's low of ₹1,435.10 and a high of ₹1,478.90.
- The company announced the execution of a Business Transfer Agreement to acquire 100% of the integrated diagnostic business undertaking of Arya Wellness Centre in Guwahati, Assam, on a slump sale basis. The cash consideration is approximately ₹46.20 crores, structured at around 8 to 9 times FY26 IND AS EBITDA, providing an established operating base in the North-East region.
- Trading volume was 0.40 times the 20-day average daily volume.
Why is Vijaya Diagnostic Centre share price falling on 30 October 2026?
Vijaya Diagnostic Centre Ltd. (VIJAYA) fell 1.26% during the trading session, closing at ₹1,445.70 after moving between a day's low of ₹1,435.10 and a high of ₹1,478.90.
The broader market and sector moved in the opposite direction during the session, as the Nifty benchmark rose 0.51% and the Nifty Pharma sector index advanced 1.55%. While the stock had registered positive returns over the preceding 5 trading days with a gain of 4.05%, today's pullback reflects mild profit-taking or sector divergence rather than broad-based participation.
The company's recent corporate activity includes securing shareholder approval at its 24th Annual General Meeting held on September 24, 2026, for a final dividend of ₹2 per equity share and amendments to its employee stock option plan. Additionally, the company previously announced a 100% acquisition of the integrated diagnostic business undertaking of Arya Wellness Centre in Guwahati, Assam, for ₹46.20 crores on a slump sale basis, expanding its footprint into North-East India.
49,563 shares traded by 30 October 2026 · 03:25 PM IST. This compares with a 20-day average daily volume of 1.22 lakh shares (0.40 times). The five-day average daily volume was 1.01 lakh shares. Separately, the NSE report for 29 October 2026 showed 45,385 shares delivered, representing 55.04% of that day’s traded volume. The same report recorded 12,413 trades.
The stock declined by 1.26% on lower-than-average volume despite gains in the broader Nifty and Nifty Pharma sector. Given the positive 4.05% return over the preceding 5 trading days, today's move aligns best with a mild technical pullback and profit-taking following recent strength rather than any same-day fundamental catalyst.
Latest Company Developments
The company announced the execution of a Business Transfer Agreement to acquire 100% of the integrated diagnostic business undertaking of Arya Wellness Centre in Guwahati, Assam, on a slump sale basis. The cash consideration is approximately ₹46.20 crores, structured at around 8 to 9 times FY26 IND AS EBITDA, providing an established operating base in the North-East region.
This acquisition marks the company's geographical foray into Assam, expanding its diagnostic network beyond its existing stronghold in Southern and Eastern India.
General Updates – Investor Presentation – 100% Acquisition of integrated diagnostic business undertaking of Arya Wellness Centre, Guwahati, Asssam.
Appointment of Mr Venkata Naresh Yallapragada as Other of the company effective. September 02, 2026.
Ownership & Transaction Activity
Mutual Fund Holdings
Mutual funds held 31.44% on 30 September 2026. This compares with 30.66% on 30 June 2026, a change of +0.78 percentage points.
The filing reported 27 MF/UTI holders.
What to Watch Next
- Progress on the acquisition of Arya Wellness Centre in Guwahati and its anticipated completion timeline by late 2026.
- Upcoming financial results scheduled for board consideration in November 2026.
- Cash market delivery percentages and trading volume relative to the 20-day average of 0.40x.
- Integration milestones regarding the expansion into the North-East diagnostic market.
More Vijaya Diagnostic Centre news and dated analysis →
Frequently Asked Questions
What is the latest Vijaya Diagnostic Centre company news?
The company announced the execution of a Business Transfer Agreement to acquire 100% of the integrated diagnostic business undertaking of Arya Wellness Centre in Guwahati, Assam, on a slump sale basis. The cash consideration is approximately ₹46.20 crores, structured at around 8 to 9 times FY26 IND AS EBITDA, providing an established operating base in the North-East region.
How strong was Vijaya Diagnostic Centre’s trading volume?
49,563 shares traded, 0.40 times the 20-day average daily volume. The price and volume data are dated 30 October 2026 · 03:25 PM IST.
Do the mutual-fund figures show buying today?
They show holdings on 30 September 2026. Quarterly holdings do not identify purchases made on the article date.
Research & analysis: WittyTrades Research Desk
Reviewed by: Mohanish Sanghavi — SEBI Registered Research Analyst
Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.